Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Alpine Immune treats first patient in Phase I trial of ALPN-101

The Phase I trial will assess single and multiple-ascending intravenous and / or subcutaneous doses. Credit: Hush Naidoo on Unsplash.



  • Alpine Immune treats first patient in Phase I trial of ALPN-101

Go Top